These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

291 related items for PubMed ID: 21707858

  • 1. Serum homocysteine and physical exercise in patients with Parkinson's disease.
    Nascimento CM, Stella F, Garlipp CR, Santos RF, Gobbi S, Gobbi LT.
    Psychogeriatrics; 2011 Jun; 11(2):105-12. PubMed ID: 21707858
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Plasma homocysteine level and its relationship to clinical profile in Parkinson's disease patients at the Lagos University Teaching Hospital.
    Ojo OO, Oladipo OO, Ojini FI, Sanya EO, Danesi MA, Okubadejo NU.
    West Afr J Med; 2011 Jun; 30(5):319-24. PubMed ID: 22752818
    [Abstract] [Full Text] [Related]

  • 4. Hyperhomocysteinemia due to levodopa treatment as a risk factor for osteoporosis in patients with Parkinson's disease.
    Lee SH, Kim MJ, Kim BJ, Kim SR, Chun S, Kim HK, Ryu JS, Kim GS, Lee MC, Chung SJ, Koh JM.
    Calcif Tissue Int; 2010 Feb; 86(2):132-41. PubMed ID: 20049422
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Homocysteine is not associated with global motor or cognitive measures in nondemented older Parkinson's disease patients.
    Camicioli RM, Bouchard TP, Somerville MJ.
    Mov Disord; 2009 Jan 30; 24(2):176-82. PubMed ID: 18951534
    [Abstract] [Full Text] [Related]

  • 9. Methylenetetrahydrofolate reductase polymorphisms and plasma homocysteine in levodopa-treated and non-treated Parkinson's disease patients.
    Yuan RY, Sheu JJ, Yu JM, Hu CJ, Tseng IJ, Ho CS, Yeh CY, Hung YL, Chiang TR.
    J Neurol Sci; 2009 Dec 15; 287(1-2):64-8. PubMed ID: 19786283
    [Abstract] [Full Text] [Related]

  • 10. Elevated plasma homocysteine level in patients with Parkinson disease: motor, affective, and cognitive associations.
    O'Suilleabhain PE, Sung V, Hernandez C, Lacritz L, Dewey RB, Bottiglieri T, Diaz-Arrastia R.
    Arch Neurol; 2004 Jun 15; 61(6):865-8. PubMed ID: 15210523
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Hyperhomocysteinemia in L-dopa treated Parkinson's disease patients: effect of cobalamin and folate administration.
    Lamberti P, Zoccolella S, Armenise E, Lamberti SV, Fraddosio A, de Mari M, Iliceto G, Livrea P.
    Eur J Neurol; 2005 May 15; 12(5):365-8. PubMed ID: 15804266
    [Abstract] [Full Text] [Related]

  • 15. Clinical significance of homocysteine (hcy) on dementia in Parkinson's disease (PD).
    Song IU, Kim JS, Park IS, Kim YD, Cho HJ, Chung SW, Lee KS.
    Arch Gerontol Geriatr; 2013 May 15; 57(3):288-91. PubMed ID: 23706974
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Reduced plasma homocysteine levels in levodopa/entacapone treated Parkinson patients.
    Valkovic P, Benetin J, Blazícek P, Valkovicová L, Gmitterová K, Kukumberg P.
    Parkinsonism Relat Disord; 2005 Jun 15; 11(4):253-6. PubMed ID: 15878587
    [Abstract] [Full Text] [Related]

  • 18. Homocysteine Levels in Parkinson's Disease: Is Entacapone Effective?
    Kocer B, Guven H, Comoglu SS.
    Biomed Res Int; 2016 Jun 15; 2016():7563705. PubMed ID: 27493964
    [Abstract] [Full Text] [Related]

  • 19. Parkinsonism in multiple system atrophy: natural history, severity (UPDRS-III), and disability assessment compared with Parkinson's disease.
    Tison F, Yekhlef F, Chrysostome V, Balestre E, Quinn NP, Poewe W, Wenning GK.
    Mov Disord; 2002 Jul 15; 17(4):701-9. PubMed ID: 12210859
    [Abstract] [Full Text] [Related]

  • 20. Modest increase in plasma homocysteine follows levodopa initiation in Parkinson's disease.
    O'Suilleabhain PE, Bottiglieri T, Dewey RB, Sharma S, Diaz-Arrastia R.
    Mov Disord; 2004 Dec 15; 19(12):1403-8. PubMed ID: 15390053
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.